Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 8 Neoplasms 3 Hemangioma, Capillary 2 Anxiety Disorders 2 Weight Loss 1 Vomiting 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Urinary Bladder Neoplasms 1 Shoulder Pain 1 Respiratory Aspiration 1 Psychomotor Agitation 1 Prostatic Neoplasms 1 Premature Birth 1 Polycystic Ovary Syndrome 1 Pediatric Obesity 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Ovarian Cysts 1 Obesity 1 Neuromuscular Diseases 1 Neuroblastoma 1 Nasopharyngeal Carcinoma 1 Myofibroma 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Multiple Myeloma 1 Menstruation Disturbances 1 Lymphoma, Follicular 1 Lung Neoplasms 1

Interventions

Gemcitabine 406 Oxaliplatin 131 Fluorouracil 125 130-nm albumin-bound paclitaxel 108 Capecitabine 100 Albumin-Bound Paclitaxel 90 Leucovorin 88 Irinotecan 87 Radiotherapy 76 Radiosurgery 64 Taxes 63 Cisplatin 56 Erlotinib Hydrochloride 44 Drug Therapy 42 folfirinox 40 Magnetic Resonance Spectroscopy 39 pembrolizumab 35 Blood Specimen Collection 33 S 1 (combination) 31 Pancreaticoduodenectomy 31 Docetaxel 31 Nivolumab 30 Bevacizumab 30 Biopsy 26 Surgical Procedures, Operative 25 Cyclophosphamide 25 irinotecan sucrosofate 24 Specimen Handling 24 Radiation 22 Standard of Care 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Neoplasms × Population Groups × Clear all

NCT06868693 2025-03-11

PEACE

Azienda Unita Sanitaria Locale di Piacenza

Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡